STMN1 and breast carcinoma: For example, high levels of Stathmin 1 (STMN1) or oncoprotein 18 are associated with a poor prognosis and chemotherapy resistance in various cancers, including breast cancer, indicating that specific biomarkers can inform clinicians about the likely course of the disease and guide treatment decisions [120].